APA

Azad N. S., Posadas E. M., Kwitkowski V. E., Steinberg S. M., Jain L., Annunziata C. M., Minasian L., Sarosy G., Kotz H. L., Premkumar A., Cao L., McNally D., Chow C., Chen H. X., Wright J. J., Figg W. D. & Kohn E. C. (20080814). Combination targeted therapy with sorafenib and bevacizumab results in enhanced toxicity and antitumor activity. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Chicago

Azad Nilofer S, Posadas Edwin M, Kwitkowski Virginia E, Steinberg Seth M, Jain Lokesh, Annunziata Christina M, Minasian Lori, Sarosy Gisele, Kotz Herbert L, Premkumar Ahalya, Cao Liang, McNally Deborah, Chow Catherine, Chen Helen X, Wright John J, Figg William D and Kohn Elise C. 20080814. Combination targeted therapy with sorafenib and bevacizumab results in enhanced toxicity and antitumor activity. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Harvard

Azad N. S., Posadas E. M., Kwitkowski V. E., Steinberg S. M., Jain L., Annunziata C. M., Minasian L., Sarosy G., Kotz H. L., Premkumar A., Cao L., McNally D., Chow C., Chen H. X., Wright J. J., Figg W. D. and Kohn E. C. (20080814). Combination targeted therapy with sorafenib and bevacizumab results in enhanced toxicity and antitumor activity. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

MLA

Azad Nilofer S, Posadas Edwin M, Kwitkowski Virginia E, Steinberg Seth M, Jain Lokesh, Annunziata Christina M, Minasian Lori, Sarosy Gisele, Kotz Herbert L, Premkumar Ahalya, Cao Liang, McNally Deborah, Chow Catherine, Chen Helen X, Wright John J, Figg William D and Kohn Elise C. Combination targeted therapy with sorafenib and bevacizumab results in enhanced toxicity and antitumor activity. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 20080814.